Logo

Biogen Licenses Incyte’s LifeSeq Gold, LifeTools

Jan 28, 2000
Premium

P

ALO ALTO, Calif.--Biogen has licensed the LifeSeq Gold database and LifeTools enterprise-wide data management software from Incyte Pharmaceuticals, which could receive future milestone payments and royalties on sales of products developed with Incyte technology and database information. Financial terms were not disclosed. Used for drug discovery, LifeSeq Gold provides views of genes, their function, and their role in disease development. LifeTools will enable Biogen researchers to process, store, analyze, and manage the ever-growing amounts of genomic data.

Filed under

Informatics
Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.